Optiver Holding
LKFT

Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Optiver Holding’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,900
Closed -$77.2K – 706
2023
Q4 		$77.2K Sell
1,900
-6,400
-77% -$236K ﹤0.01% 413
2023
Q3 		$287K Sell
8,300
-67,200
-89% -$2.62M ﹤0.01% 424
2023
Q2 		$3.07M Sell
75,500
-16,700
-18% -$681K ﹤0.01% 334
2023
Q1 		$3.56M Buy
92,200
+9,800
+12% +$403K ﹤0.01% 336
2022
Q4 		$3.66M Sell
82,400
-127,900
-61% -$5.38M ﹤0.01% 284
2022
Q3 		$8.97M Buy
210,300
+46,600
+28% +$2.39M 0.01% 188
2022
Q2 		$9.13M Sell
163,700
-39,600
-19% -$2.35M 0.01% 166
2022
Q1 		$12.6M Sell
203,300
-40,900
-17% -$2.5M 0.01% 135
2021
Q4 		$13M Buy
244,200
+77,300
+46% +$4.03M 0.01% 155
2021
Q3 		$8.78M Sell
166,900
-8,600
-5% -$511K 0.01% 143
2021
Q2 		$12.1M Buy
+175,500
New +$13.4M 0.02% 109
2021
Q1 		– Hold
0
– – – 69

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Optiver Holding's LKFT Position: Q2 2026 in Review

Optiver Holding sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 26,535 shares — an estimated $796K sold.

Optiver Holding first reported a position in LKFT in Q2 2021 and held it in 15 quarters. The position peaked at $17.4M in Q2 2022. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Optiver Holding reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 26,535 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $796K.
  • Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and held it in 15 quarters.
  • Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.